Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data

Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data

Background: Combination therapy using an immune checkpoint inhibitor (ICI) and a tyrosine kinase inhibitor (TKI) is the standard first-line treatment for metastatic renal cell carcinoma (RCC). Oral TKIs enhance patient autonomy but require strict adherence and persistence. Methods: We analyzed adult...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhaohui Liao Arter, David J Benjamin, Yen Cao, Jorge Farias, Ranjit Kumar Thirumaran, Michael Forsyth, Nataliya Mar, Arash Rezazadeh Kalebasty
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.1177/11795549251341877
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/11795549251341877

Similar Items